Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 28;8(4):62.
doi: 10.3390/ijns8040062.

Liquid Chromatography-Tandem Mass Spectrometry in Newborn Screening Laboratories

Affiliations
Review

Liquid Chromatography-Tandem Mass Spectrometry in Newborn Screening Laboratories

Michael H Gelb et al. Int J Neonatal Screen. .

Abstract

Tandem mass spectrometry (MS/MS) is the most universal platform currently available for the analysis of enzymatic activities and biomarkers in dried blood spots (DBS) for applications in newborn screening (NBS). Among the MS/MS applications in NBS, the most common is flow-injection analysis (FIA-) MS/MS, where the sample is introduced as a bolus injection into the mass spectrometer without the prior fractionation of analytes. Liquid chromatography combined with MS/MS (LC-MS/MS) has been employed for second-tier tests to reduce the false-positive rate associated with several nonspecific screening markers, beginning two decades ago. More recently, LC-MS/MS has been applied to primary screening for new conditions for which FIA-MS/MS or other methods, including genomic screening, are not yet adequate. In addition to providing a list of the currently used LC-MS/MS-based assays for NBS, the authors share their experience regarding the maintenance requirements of LC-MS/MS vs. FIA-MS/MS systems. The consensus is that the maintenance of LC-MS/MS and FIA-MS/MS instrumentation is similar, and LC-MS/MS has the advantage of allowing for a larger number of diseases to be screened for in a multiplex, cost-effective fashion with a high throughput and an adequate turnaround time.

Keywords: dried blood spots; inborn errors of metabolism; liquid chromatography; newborn screening; reflex testing; tandem mass spectrometry.

PubMed Disclaimer

Conflict of interest statement

M.H. Gelb and H. Khaledi are co-founders of GelbChem, LLC.

References

    1. Chace D.H. Mass spectrometry in newborn and metabolic screening: Historical perspective and future directions. J. Mass Spectrom. 2009;44:163–170. doi: 10.1002/jms.1528. - DOI - PubMed
    1. Gelb M.H. Newborn Screening for Lysosomal Storage Diseases: Methodologies, Screen Positive Rates, Normalization of Datasets, Second-Tier Tests, and Post-Analysis Tools. Int. J. Neonatal Screen. 2018;4:23. doi: 10.3390/ijns4030023. - DOI - PMC - PubMed
    1. La Marca G., Casetta B., Malvagia S., Guerrini R., Zammarchi E. New strategy for the screening of lysosomal storage disorders: The use of the online trapping-and-cleanup liquid chromatography/mass spectrometry. Anal. Chem. 2009;81:6113–6121. doi: 10.1021/ac900504s. - DOI - PubMed
    1. Metz T.F., Mechtler T.P., Orsini J.J., Martin M., Shushan B., Herman J.L., Ratschmann R., Item C.B., Streubel B., Herkner K.R., et al. Simplified newborn screening protocol for lysosomal storage disorders. Clin. Chem. 2011;57:1286–1294. doi: 10.1373/clinchem.2011.164640. - DOI - PubMed
    1. Scott C.R., Elliott S., Hong X., Huang J.Y., Kumar A.B., Yi F., Pendem N., Chennamaneni N.K., Gelb M.H. Newborn Screening for Mucopolysaccharidoses: Results of a Pilot Study with 100,000 Dried Blood Spots. J. Pediatr. 2020;216:204–207. doi: 10.1016/j.jpeds.2019.09.036. - DOI - PMC - PubMed